AFC
GILD icon

Ares Financial Consulting’s Gilead Sciences GILD Stock Holding History

Ares Financial Consulting’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$75.3K Buy
596
+19
+3% +$2.5K 0.05% 172
2026
Q1 		$81K Buy
577
+351
+155% +$49.2K 0.06% 157
2025
Q4 		$27.7K Buy
+226
New +$27.5K 0.03% 221

Other funds holding GILD

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Ares Financial Consulting's GILD Position: Q2 2026 in Review

Ares Financial Consulting increased its Gilead Sciences (GILD) stake by 3.3% in Q2 2026, buying an estimated $2.5K and bringing the position to 596 shares worth $75.3K. The position accounts for 0.05% of the portfolio, ranked #172.

Ares Financial Consulting first reported a position in GILD in Q4 2025 and has held it in 3 quarters since. The position peaked at $81K in Q1 2026. 1,239 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Ares Financial Consulting held 596 shares of Gilead Sciences worth $75.3K as of Q2 2026.
  • Ares Financial Consulting bought 19 Gilead Sciences shares in Q2 2026, an estimated $2.5K.
  • Gilead Sciences made up 0.05% of Ares Financial Consulting's portfolio in Q2 2026, its #172 holding.
  • Ares Financial Consulting first reported a position in Gilead Sciences in Q4 2025 and has held it in 3 quarters since.
  • Ares Financial Consulting's Gilead Sciences position peaked at $81K in Q1 2026.
  • 1,239 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Ares Financial Consulting's 13F filing for Q2 2026, filed 9 Jul 2026.